文献速递肾移植

美国抢先肾移植差异趋势

Trends in Disparities in Preemptive Kidney Transplantation in the United States.
PubMed 文献 · Clin J Am Soc Nephrol · 2019-09-26

该研究基于美国移植受者科学登记系统2000至2018年成人死亡供者肾移植数据,分析2014年新肾脏分配系统(KAS)实施前后抢先移植比例及差异变化。结果显示KAS后抢先移植比例从9.0%升至9.8%,但种族和医保差异持续存在,少数族裔和Medicare患者差异加剧。

要点

  • KAS实施后抢先死亡供者肾移植比例由9.0%升至9.8%。
  • Medicare患者抢先移植几率显著低于私人保险者且KAS后差距扩大。
  • 黑人和西班牙裔患者抢先移植几率持续低于白人且KAS后差距扩大。

核心结论

  • KAS后抢先死亡供者肾移植比例略有增加,但抢先移植差异持续存在,且种族少数群体和Medicare患者差异加剧。

研究设计与样本

  • 基于美国移植受者科学登记系统的回顾性队列研究,纳入2000至2018年成人死亡供者肾移植受者,使用逻辑回归分析。

主要发现

  • 抢先移植比例从KAS前的9.0%升至KAS后的9.8%,KAS后抢先移植优势比为1.10(95%CI 1.06-1.14)。
  • 抢先移植受者更可能为白人、年龄较大、女性、教育程度较高、持有私人保险,以及ESKD病因非糖尿病或高血压。
  • KAS政策时代显著修饰抢先移植与种族、年龄、保险状态及HLA零错配的关联(交互P<0.05)。
  • Medicare患者相对私人保险持有者的抢先移植调整OR从KAS前0.26(95%CI 0.25-0.27)降至KAS后0.20(95%CI 0.18-0.22)。
  • 黑人和西班牙裔患者相对白人患者的抢先移植调整OR分别从0.48(95%CI 0.45-0.51)降至0.41(95%CI 0.37-0.45)和从0.43(95%CI 0.40-0.47)降至0.40(95%CI 0.36-0.46)。

临床怎么用

  • 肾内科医生应关注Medicare参保及少数族裔ESKD患者抢先移植机会的持续差异,积极评估并转诊进行肾移植。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Long wait times for deceased donor kidneys and low rates of preemptive wait-listing have limited preemptive transplantation in the United States. We aimed to assess trends in preemptive deceased donor transplantation with the introduction of the new Kidney Allocation System (KAS) in 2014 and identify whether key disparities in preemptive transplantation have changed. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We identified adult deceased donor kidney transplant recipients in the United States from 2000 to 2018 using the Scientific Registry of Transplant Recipients. Preemptive transplantation was defined as no dialysis before transplant. Associations between recipient, donor, transplant, and policy era characteristics and preemptive transplantation were calculated using logistic regression. To test for modification by KAS policy era, an interaction term between policy era and each characteristic of interest was introduced in bivariate and adjusted models. RESULTS: The proportion of preemptive transplants increased after implementation of KAS from 9.0% to 9.8%, with 1.10 (95% confidence interval [95% CI], 1.06 to 1.14) times higher odds of preemptive transplantation post-KAS compared with pre-KAS. Preemptive recipients were more likely to be white, older, female, more educated, hold private insurance, and have ESKD cause other than diabetes or hypertension. Policy era significantly modified the association between preemptive transplantation and race, age, insurance status, and Human Leukocyte Antigen zero-mismatch (interaction P<0.05). Medicare patients had a significantly lower odds of preemptive transplantation relative to private insurance holders (pre-KAS adjusted OR, [aOR] 0.26; [95% CI, 0.25 to 0.27], to 0.20 [95% CI, 0.18 to 0.22] post-KAS). Black and Hispanic patients experienced a similar phenomenon (aOR 0.48 [95% CI, 0.45 to 0.51] to 0.41 [95% CI, 0.37 to 0.45] and 0.43 [95% CI, 0.40 to 0.47] to 0.40 [95% CI, 0.36 to 0.46] respectively) compared with white patients. CONCLUSIONS: Although the proportion of deceased donor kidney transplants performed preemptively increased slightly after KAS, disparities in preemptive kidney transplantation persisted after the 2014 KAS policy changes and were exacerbated for racial minorities and Medicare patients.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. King KL, Husain SA, Jin Z, et al. Trends in Disparities in Preemptive Kidney Transplantation in the United States. Clin J Am Soc Nephrol. 2019. PMID: 31413065. doi:10.2215/CJN.03140319

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。